Back to Search
Start Over
Comparison of the effects of 7.2% hypertonic saline and 20% mannitol on whole blood coagulation and platelet function in dogs with suspected intracranial hypertension - a pilot study.
- Source :
-
BMC veterinary research [BMC Vet Res] 2017 Jun 19; Vol. 13 (1), pp. 185. Date of Electronic Publication: 2017 Jun 19. - Publication Year :
- 2017
-
Abstract
- Background: Hyperosmolar therapy with either mannitol or hypertonic saline (HTS) is commonly used in the treatment of intracranial hypertension (ICH). In vitro data indicate that both mannitol and HTS affect coagulation and platelet function in dogs. The aim of this study was to compare the effects of 20% mannitol and 7.2% HTS on whole blood coagulation using rotational thromboelastometry (ROTEM®) and platelet function using a platelet function analyzer (PFA®) in dogs with suspected ICH. Thirty client-owned dogs with suspected ICH needing osmotherapy were randomized to receive either 20% mannitol (5 ml/kg IV over 15 min) or 7.2% HTS (4 ml/kg IV over 5 min). ROTEM® (EXTEM® and FIBTEM® assays) and PFA® analyses (collagen/ADP cartridges) were performed before (T <subscript>0</subscript> ), as well as 5 (T <subscript>5</subscript> ), 60 (T <subscript>60</subscript> ) and 120 (T <subscript>120</subscript> ) minutes after administration of HTS or mannitol. Data at T <subscript>5</subscript> , T <subscript>60</subscript> and T <subscript>120</subscript> were analyzed as a percentage of values at T <subscript>0</subscript> for comparison between groups, and as absolute values for comparison between time points, respectively.<br />Results: No significant difference was found between the groups for the percentage change of any parameter at any time point except for FIBTEM® clotting time. Within each group, no significant difference was found between time points for any parameter except for FIBTEM® clotting time in the HTS group, and EXTEM® and FIBTEM® maximum clot firmness in the mannitol group. Median ROTEM® values lay within institutional reference intervals in both groups at all time points, whereas median PFA® values were above the reference intervals at T <subscript>5</subscript> (both groups) and T <subscript>60</subscript> (HTS group).<br />Conclusions: Using currently recommended doses, mannitol and HTS do not differ in their effects on whole blood coagulation and platelet function in dogs with suspected ICH. Moreover, no relevant impairment of whole blood coagulation was found following treatment with either solution, whereas a short-lived impairment of platelet function was found after both solutions.
- Subjects :
- Animals
Blood Platelets drug effects
Cohort Studies
Dogs
Female
Hematocrit veterinary
Intracranial Hypertension blood
Intracranial Hypertension drug therapy
Male
Osmolar Concentration
Pilot Projects
Platelet Count veterinary
Platelet Function Tests veterinary
Prospective Studies
Blood Coagulation drug effects
Dog Diseases drug therapy
Intracranial Hypertension veterinary
Mannitol therapeutic use
Saline Solution, Hypertonic therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1746-6148
- Volume :
- 13
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- BMC veterinary research
- Publication Type :
- Academic Journal
- Accession number :
- 28629456
- Full Text :
- https://doi.org/10.1186/s12917-017-1108-2